TransMedics Group, Inc. (TMDX)
TransMedics Group, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
TransMedics Group, Inc. (TMDX) is a Medical - Devices company based in US with a market capitalization of $2.3B. Revenue grew 37.1% year-over-year and the company generated $133.6M in free cash flow. This page tracks TMDX's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
US · 728 employees · IPO May 2, 2019
Valuation
Valuation & price
$63.20as of May 17, 2026· -58.0% vs 52w high
13.5
P/E ratio
Latest-FY diluted EPS
4.93
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$2.3B
Market cap
37.1%
Revenue growth (YoY)
59.9%
Gross margin
$133.6M
Free cash flow (USD)
-$18.7M
Net debt
Net cash position
2.3%
Share dilution
1/5
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2016 → 2025
Free cash flow by year
2016 → 2025
Gross margin by year
2021 → 2025
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
1
Insider sells · 90 days
Earnings
Last report: 10-Q filed May 5, 2026
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
Questions
Frequently asked questions
What is TransMedics Group, Inc.'s market cap?
TransMedics Group, Inc. (TMDX) has a market capitalization of $2.3B.
What is TMDX's P/E ratio?
TMDX trades at a price-to-earnings ratio of 13.5, based on its latest fiscal-year diluted earnings per share and the most recent cached price.
What is TMDX's price-to-book (P/B) ratio?
TMDX trades at 4.93 times book value per share.
Are insiders buying TMDX stock?
SEC Form 4 filings show no open-market insider buys at TransMedics Group, Inc. in the last 90 days (1 sell).
Same arena
Related companies in Medical - Devices
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.